v3.26.1
Summary of Significant Accounting Policies - Schedule of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Revenue [Line Items]    
Total revenue $ 398 $ 381
Clinical trial revenue [Member]    
Schedule of Revenue [Line Items]    
Total revenue 378 259
Contract manufacturing lease revenue [Member]    
Schedule of Revenue [Line Items]    
Total revenue   6
Contract manufacturing revenue [Member]    
Schedule of Revenue [Line Items]    
Total revenue $ 20 $ 116